Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Surgery ; 148(4): 752-7; discussion 757-8, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20708765

RESUMO

BACKGROUND: Pseudoangiomatous stromal hyperplasia (PASH) is a benign, proliferative lesion of the breast whose clinical relevance, presentation, and optimal treatment remains described incompletely. The purpose of this study is to review the clinical, radiologic, and histopathologic features and appropriate management. METHODS: Patients diagnosed with PASH were identified from our pathology database between 2000 and 2009. Clinicopathologic data including presentation, diagnosis, imaging, and histology were reviewed. All specimens were confirmed by a single pathologist. RESULTS: We identified PASH in 80 patients. Median follow-up was 3.71 years (range, 0.45-9.42). Age ranged from 12 to 65 (median, 45) and 95% were female. Lesions were palpable in 56% and found on imaging in the remainder. Core biopsy was performed in 65 of 80 patients (81%), which confirmed a diagnosis of PASH in 65%. The other 23 of 65 patients (35%) required operative excision for diagnosis. There was a progression rate of 26% in the observation arm versus 13% in the excision arm. A diagnosis of cancer or carcinoma in situ was seen in 30% at or before the diagnosis of PASH. CONCLUSION: PASH may present as a mass, radiologic lesion, or incidentally in pathology specimens. It may be associated with cancerous or precancerous lesions. A diagnosis on core biopsy in the absence of suspicious radiologic features may be managed with follow-up and imaging at a 6-month interval. In this series, 35% of patients with PASH had a negative core biopsy. Growth, suspicious radiologic findings, or inconclusive biopsy warrants surgical excision. Close surveillance is necessary given its recurrence rate of 13-26%.


Assuntos
Doenças Mamárias/patologia , Mama/patologia , Adolescente , Adulto , Idoso , Biópsia por Agulha , Doenças Mamárias/diagnóstico , Neoplasias da Mama/diagnóstico , Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/diagnóstico , Carcinoma Ductal de Mama/patologia , Carcinoma Intraductal não Infiltrante/diagnóstico , Carcinoma Intraductal não Infiltrante/patologia , Criança , Bases de Dados Factuais , Feminino , Humanos , Hiperplasia , Masculino , Mamografia , Pessoa de Meia-Idade , Ultrassonografia Mamária , Adulto Jovem
2.
J Burn Care Res ; 29(3): 555-8, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18388562

RESUMO

Toxic epidermal necrolysis syndrome (TENS) is a severe but rare skin reaction leading to epidermal desquamation of greater than 30% of the TBSA. It is most commonly precipitated by the administration of medication. Frequent complications of this syndrome include local wound infections, respiratory, mucocutaneous, and ocular complications. Ecthyma gangrenosum (EG) is a rare disease characterized by a milliary seeding of the cutaneous tissue with Gram-negative bacteria; it is most commonly seen in immunocompromised individuals. Here we report a 3-year-old boy who developed EG subsequent to TENS. Although he had a complicated and prolonged hospital course, he survived these series of events. To our knowledge, this is the first reported case of TENS/EG in the pediatric population, and the first report of survivability following these illnesses.


Assuntos
Ectima/etiologia , Gangrena/etiologia , Infecções por Bactérias Gram-Negativas/microbiologia , Síndrome de Stevens-Johnson/complicações , Antibacterianos/uso terapêutico , Pré-Escolar , Ectima/tratamento farmacológico , Ectima/microbiologia , Gangrena/tratamento farmacológico , Gangrena/microbiologia , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Humanos , Imipenem/uso terapêutico , Masculino , Fatores de Risco , Transplante de Pele , Síndrome de Stevens-Johnson/microbiologia , Síndrome de Stevens-Johnson/cirurgia , Tobramicina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...